Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Braz J Urol (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046 |
Resumo: | Objective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different signs of potential prostate cancer. Complications were assessed both during the procedure and one week later. After the procedure, urine samples were collected for culture. The rate of post-biopsy complications, hospital visits and hospitalizations were also analyzed. Ciprofloxacin (500 mg) was administered two hours before, and eight hours after the procedure. Results The overall rate of post-biopsy complications was 87.32%, being 5.4% of those considered major complications due to hemorrhage, or to urinary retention. Eight patients required hospital treatment post-biopsy. Fever occurred in just one patient (0.29%). There was no incidence of orchitis, epididymitis, prostatitis, septicemia, hospitalization, or death. The urine culture showed positive results in five patients (2.15%). Conclusion One-day prophylaxis with ciprofloxacin proved to be safe and effective in the prevention of infectious complications following 16-core prostate biopsies. |
id |
SBU-1_d6e0bdaf2ee3a977ac0c24b1b6afc09f |
---|---|
oai_identifier_str |
oai:scielo:S1677-55382015000100046 |
network_acronym_str |
SBU-1 |
network_name_str |
International Braz J Urol (Online) |
repository_id_str |
|
spelling |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsyprostateprostatic neoplasmsbiopsycomplications Objective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different signs of potential prostate cancer. Complications were assessed both during the procedure and one week later. After the procedure, urine samples were collected for culture. The rate of post-biopsy complications, hospital visits and hospitalizations were also analyzed. Ciprofloxacin (500 mg) was administered two hours before, and eight hours after the procedure. Results The overall rate of post-biopsy complications was 87.32%, being 5.4% of those considered major complications due to hemorrhage, or to urinary retention. Eight patients required hospital treatment post-biopsy. Fever occurred in just one patient (0.29%). There was no incidence of orchitis, epididymitis, prostatitis, septicemia, hospitalization, or death. The urine culture showed positive results in five patients (2.15%). Conclusion One-day prophylaxis with ciprofloxacin proved to be safe and effective in the prevention of infectious complications following 16-core prostate biopsies. Sociedade Brasileira de Urologia2015-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046International braz j urol v.41 n.1 2015reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/S1677-5538.IBJU.2015.01.08info:eu-repo/semantics/openAccessChambó,Renato CarettaTsuji,Fábio HissachiYamamoto,Hamilton AkihissaJesus,Carlos Márcio Nóbrega deeng2015-04-07T00:00:00Zoai:scielo:S1677-55382015000100046Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2015-04-07T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false |
dc.title.none.fl_str_mv |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
spellingShingle |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy Chambó,Renato Caretta prostate prostatic neoplasms biopsy complications |
title_short |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_full |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_fullStr |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_full_unstemmed |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
title_sort |
Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy |
author |
Chambó,Renato Caretta |
author_facet |
Chambó,Renato Caretta Tsuji,Fábio Hissachi Yamamoto,Hamilton Akihissa Jesus,Carlos Márcio Nóbrega de |
author_role |
author |
author2 |
Tsuji,Fábio Hissachi Yamamoto,Hamilton Akihissa Jesus,Carlos Márcio Nóbrega de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Chambó,Renato Caretta Tsuji,Fábio Hissachi Yamamoto,Hamilton Akihissa Jesus,Carlos Márcio Nóbrega de |
dc.subject.por.fl_str_mv |
prostate prostatic neoplasms biopsy complications |
topic |
prostate prostatic neoplasms biopsy complications |
description |
Objective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different signs of potential prostate cancer. Complications were assessed both during the procedure and one week later. After the procedure, urine samples were collected for culture. The rate of post-biopsy complications, hospital visits and hospitalizations were also analyzed. Ciprofloxacin (500 mg) was administered two hours before, and eight hours after the procedure. Results The overall rate of post-biopsy complications was 87.32%, being 5.4% of those considered major complications due to hemorrhage, or to urinary retention. Eight patients required hospital treatment post-biopsy. Fever occurred in just one patient (0.29%). There was no incidence of orchitis, epididymitis, prostatitis, septicemia, hospitalization, or death. The urine culture showed positive results in five patients (2.15%). Conclusion One-day prophylaxis with ciprofloxacin proved to be safe and effective in the prevention of infectious complications following 16-core prostate biopsies. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1677-5538.IBJU.2015.01.08 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
dc.source.none.fl_str_mv |
International braz j urol v.41 n.1 2015 reponame:International Braz J Urol (Online) instname:Sociedade Brasileira de Urologia (SBU) instacron:SBU |
instname_str |
Sociedade Brasileira de Urologia (SBU) |
instacron_str |
SBU |
institution |
SBU |
reponame_str |
International Braz J Urol (Online) |
collection |
International Braz J Urol (Online) |
repository.name.fl_str_mv |
International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU) |
repository.mail.fl_str_mv |
||brazjurol@brazjurol.com.br |
_version_ |
1750318074061389824 |